Morpheus8: What It Is, Cost, Results and Risks

Morpheus8 is an applicator family made by InMode.

FDA states that RF microneedling devices are Class II medical devices cleared through the 510(k) process, and consumers can look up a device's cleared indication in FDA's 510(k) database.

The first clearance under the Morpheus8 name was K192695, decided December 27, 2019; the current one is K231790, decided July 20, 2023.

A 510(k) clearance is not the process a prescription drug goes through, which is why the device is described as cleared rather than approved.

FDA describes how RF microneedling works: an array of microneedle electrodes penetrates the skin, and each needle tip delivers a small area of intense heat at a set depth within or under the skin.

The disposable tip sets how many pins reach the skin and how deep.

The 2019 clearance listed four single-use tips: a 24-pin tip, a 40-pin tip, a 12-pin tip and a "T" tip fixed at 0.5 mm.

A 2020 clearance, K200947, raised the maximum depth of the 24- and 40-pin tips from 4.0 mm to 7.0 mm and left the 12-pin tip at 4.0 mm.

InMode's provider site now lists four Burst tips — 12-pin Morpheus8 Burst Prime, 24-pin Morpheus8 Burst, 24-pin Morpheus8 Burst Resurfacing and 40-pin Morpheus8 Burst Deep — and describes Burst as delivering RF to multiple depths in a single pulse.

The Morpheus8 Body applicator is identical to the standard one except that its compatible tip is a 40-pin tip head.

InMode's provider site calls Morpheus8 "the first and only FDA cleared fractional radiofrequency device for soft tissue contraction." That is a manufacturer claim, and the second half of it is worth reading beside the 510(k) database: Lutronic's Genius device received a 2026 clearance, K253484, whose indication reads "electrocoagulation/contraction and hemostasis." Treat the "first and only" wording as the maker's marketing, not a settled fact.

The honest answer to "what does Morpheus8 treat" starts with the cleared wording, because that is all the label supports: dermatologic procedures where coagulation/contraction of soft tissue or hemostasis is needed.

The words wrinkles, acne scars, jowl tightening, fat reduction and cellulite do not appear in the indication text.

Published research has examined RF microneedling well beyond that wording — a 2021 critical review counted 42 randomized, split-face or blinded studies, with the largest groups on facial rejuvenation and acne scars and smaller groups on acne, stretch marks, excess sweating and melasma — but studied is not the same as cleared, and those studies cover the RF microneedling category, not the Morpheus8 brand specifically.

Candidacy is a licensed-provider question, and the clearest sourced lines are these.

Skin type: every Morpheus8 clearance limits energy levels above 62 mJ per pin to Fitzpatrick skin types I-IV, so darker skin types V-VI are within the labeling only at lower energies.

Regulation: FDA calls RF microneedling a medical procedure and says patients should seek a licensed health care provider with training and experience on the device they plan to use; the device itself is prescription-use.

Beyond those lines, we found no sourced Morpheus8 candidate list — no minimum or maximum age, and no list of skin or medical conditions — so treat any absolute claim about who cannot have it as unverified, and ask the provider who examines your skin.

There is no Morpheus8 price we can confirm from a named national source, so this page does not print one.

Any quote you collect is one clinic's offer for one plan — the area treated, how many sessions, which tip and settings are what it spells out — so a number copied from another website will not predict your quote.

Two sourced points will help you compare quotes.

First, courses rather than single sessions: Cleveland Clinic describes RF microneedling as typically two to four treatments, so ask whether a price is per session or for a series, and what it includes — the single-use tip, numbing, aftercare.

Second, insurance: Cleveland Clinic notes that insurance rarely covers elective cosmetic procedures such as RF microneedling, so the cost of a course is yours to carry.

The honest way to compare med spas is to ask each one what its quote covers.

The sourced expectations are slow and modest.

Cleveland Clinic says RF microneedling typically involves two to four treatments, and that results are typically best three to six months after the first treatment as new collagen forms.

A 2021 critical review of 42 studies reached a similar conclusion about the category: RF microneedling's collagen remodeling is slow and progressive, continuing to improve even 6 months after treatment.

How long results hold after that is not something we could confirm — no sourced figure states a duration for Morpheus8 specifically, so a provider's estimate is the honest answer to the how-long question.

For more on outcomes, see Morpheus8 before and after.

Evidence quality is mixed, and so are the claims around it.

A 2026 systematic review of RF microneedling for facial rejuvenation — 20 studies, 558 participants — found adverse events were mostly mild and transient, with no serious complications in the included studies; note that some of its authors work for or speak for an RF device maker.

And Cleveland Clinic draws the boundary plainly for RF microneedling: these treatments are not a replacement for surgery.

Cleveland Clinic's description of RF microneedling: done under topical numbing, takes about an hour, skin is mildly red for about a day, and most people resume their normal routine within a day.

On pain, the 2026 systematic review reported pain as typically mild to moderate.

Clinic pages sometimes use friendlier comfort language than that; given what FDA reported in 2025, we stay with the range the studies give.

FDA's framing is the one to keep in mind while you read recovery promises: RF microneedling "is a medical procedure, not a cosmetic treatment," the devices should not be used at home, and the agency says patients should seek a licensed health care provider trained on the device.

How much recovery your own plan carries — at deeper settings, for instance — is not something our sources quantify, so ask what recovery looks like at the settings planned for you.

And remember that the sourced one-day description is about RF microneedling generally, not a Morpheus8-specific figure.

The sourced picture has two layers, and both belong in the decision.

In studies and reviews, events are mostly mild.

The 2026 systematic review (20 studies, 558 participants) found erythema and swelling the most common adverse events, mostly mild and transient, with no serious complications in the included studies.

A 2021 critical review of 42 studies judged RF microneedling effective and usable in darker skin phototypes.

A 2023 review focused on Fitzpatrick skin types III-VI (35 articles) found mostly transient post-inflammatory hyperpigmentation across 7 studies, one study with prolonged hyperpigmentation and one with permanent scarring, and called much of the evidence low quality.

The second layer is what gets reported once devices reach real clinics.

A 2026 Dermatologic Surgery analysis of FDA's MAUDE database, covering January 2013 to October 2025, identified 114 RF microneedling reports containing 224 events; the most frequent were textural changes (25.0% of events), pigment changes (18.3%) and fat loss (11.6%), followed by inflammatory reactions, burns (6.3%) and pain.

A second 2026 MAUDE analysis counted 86 device reports with 145 adverse events from 2020 to 2025, with fat loss, scarring and post-inflammatory erythema most reported.

MAUDE figures are shares of reported events, not incidence rates: they show which kinds of harm appear in reports, not how likely any one patient is to experience them.

For more, see what to know if Morpheus8 ruined your skin.

Two more sourced signals are worth knowing before you book.

A single-surgeon series of 180 neck lifts, published in 2026, reported that patients with prior nonsurgical neck treatments — Morpheus8 and other RF devices, Kybella and CoolSculpting among them — showed fibrosis and loss of normal tissue planes, with longer operations and frequent contour irregularities; it is one surgeon's retrospective series with mixed treatments, not a Morpheus8 trial.

And the skin-type limits are labeling, not etiquette: above 62 mJ per pin, the clearances cover Fitzpatrick skin types I-IV only.

"Alternative" depends on what the treatment is standing in for.

If the target is texture and scarring, classic (non-RF) microneedling is the sibling category, and it is the one whose devices FDA has authorized to improve the appearance of facial acne scars, facial wrinkles and abdominal scars in people aged 22 or older — appearance wording the Morpheus8 clearance does not carry.

If the target is laxity, the field widens to ultrasound (Ultherapy), laser resurfacing for texture and sun damage, and the devices compared in our skin tightening guide.

Within RF microneedling itself, the cleared texts differ more than the marketing suggests.

Most cleared indications say electrocoagulation and hemostasis only; Morpheus8's adds contraction of soft tissue; and a few devices — Vivace, Virtue RF's Smart RF handpiece and Candela's Profound Matrix Pro — add the percutaneous treatment of facial wrinkles, within skin-type limits.

Marketing outpacing labels is the pattern to watch in this category, so the comparisons that matter are each device's actual cleared wording, the evidence for the area you want treated, and who will operate the device.

Which category fits a given face — and whether a surgical option serves you better — is a licensed-provider question, not a comparison-chart question.

A consultation that names the device, the tip and the settings, and states what the device is actually cleared for, is the one worth booking.

Morpheus8 is a prescription-use device, and FDA's advice is specific: seek care from a licensed health care provider with training and experience on RF microneedling devices, and ask your provider which device they plan to use.

On the legal question of who may operate it, AmSpa — the medical spa trade association — describes injections of prescription drugs like botulinum toxin as the practice of medicine, done by licensed professionals acting within their scope, under rules that vary by state.

For RF microneedling devices specifically, we could not confirm a national rule on who may operate one, so ask the clinic directly who will perform your treatment and under whose supervision.

Searches like "Morpheus8 near me" will surface med spas offering the brand; the operator is the thing to vet first.

Two checks do more than any review score.

Ask which device will be used — a Morpheus8 treatment should mean the InMode system with Morpheus8 applicators, not a differently named RF microneedling device — and ask for the K-number, which you can check against the cleared indication in FDA's 510(k) database.

Comparing what the clinic claims with what the clearance says is the single most revealing step you can take.